Chronic hepatitis B monitoring and treatment patterns in five European countries with different access and reimbursement policies

Antiviral Therapy

Volumn 19, Issue 3, 2014, Pages 245-257

  Arama, Victoria ^a,b   Leblebicioglu, Hakan ^c   Simon, Krzysztof ^d   Zarski, Jean Pierre ^e   Niederau, Claus ^f   Habersetzer, François ^g   Vermehren, Johannes ^h   Bludzin, Wieslawa ⁱ   Jinga, Mariana ^j   Ulusoy, Sercan ^k   Klauck, Isabelle ^l   Morais, Edith ^l   Bjork, Stefan ^m   Lescrauwaet, Benedicte ⁿ   Kamar, Driss ^o   Zeuzem, Stefan ^h   Marcellin, Patrick ^p   Botta Fridlund, Danielle ^p   Pol, Stanislas ^p   Maynard, Marianne ^p   Causse, Xavier ^p   Alric, Laurent ^p   Noumbissie, Pauline Simo ^p   Mauss, Stefan ^p   Gerken, Guido ^p   Goeser, Tobias ^p   Wiese, Manfred ^p   Busch, Heiner ^p   Schneider, Lothar ^p   Schubert, Jens ^p   Brenner, Meike ^p   Scheffrahn, Inka ^p   Dziambor, Andrzej ^p   Goryszewski, Dariusz ^p   Postawa Klosinska, Barbara ^p   Sieklucki, Jerzy ^p   Pleśniak, Robert ^p   Acalovschi, Monica ^p   Tanasescu, Coman ^p   Raducan, Lucian ^p   Sporea, Ioan ^p   Voiculescu, Mihai ^p   Chira, Olimpia ^p   Arama, Sorin Stefan ^p   Radulescu, Mihaela Andreea ^p   Nicolau, Adriana ^p   Nitescu, Doina ^p   Munteanu, Daniela Ioana ^p   Nanu, Andrei ^p   Dan, Isabel ^p   Nicolita, Diana ^p   Ionescu, Camelia ^p   Ecobici, Monica ^p   Micu, Gina ^p   Parepa, Raluca Irinel ^p   Suceveanu, Andra ^p   Usluer, Gaye ^p   Baskol, Mevlut ^p   Ozaras, Resat ^p   Esen, Saban ^p   Kartal, Elif Doyuk ^p   more..

^a CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b Prof Dr Matei Bals National Institute of Infectious Diseases   (Romania)

^c ONDOKUZ MAYIS UNIVERSITY   (Turkey)

^d WROCLAW MEDICAL UNIVERSITY   (Poland)

^e GRENOBLE UNIVERSITY HOSPITAL   (France)

^f St Josef Hospital Oberhausen   (Germany)

^g UNIVERSITÉ DE STRASBOURG   (France)

^h UNIVERSITY HOSPITAL FRANKFURT   (Germany)

ⁱ Szpital Wojew w Opolu   (Poland)

^j Central Military Hospital Bucharest   (Romania)

^k EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^l BRISTOL MYERS SQUIBB   (United States)

^m Institute of Applied Economics and Health Research   (Denmark)

ⁿ Xintera Consulting Bvba   (Belgium)

^o DOCS International   (France)

^p NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR; ENTECAVIR; LAMIVUDINE; PEGINTERFERON; TELBIVUDINE; TENOFOVIR; VIRUS DNA; ADENINE; ALPHA INTERFERON; ANTIVIRUS AGENT; GUANINE; MACROGOL DERIVATIVE; PEGINTERFERON ALPHA2A; PHOSPHONIC ACID DERIVATIVE; RECOMBINANT PROTEIN;

ADULT; ANTIVIRAL THERAPY; ARTICLE; COHORT ANALYSIS; DRUG COST; DRUG USE; FEMALE; FOLLOW UP; FRANCE; GERMANY; HEALTH CARE POLICY; HEALTH CARE UTILIZATION; HEALTH SERVICE; HEPATITIS B; HOSPITALIZATION; HUMAN; LABORATORY TEST; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PATIENT MONITORING; POLAND; PRIORITY JOURNAL; PROSPECTIVE STUDY; REIMBURSEMENT; ROMANIA; TURKEY (REPUBLIC); AMBULATORY MONITORING; ANALOGS AND DERIVATIVES; BLOOD; DRUG EFFECTS; ECONOMICS; EUROPE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; MIDDLE AGED; PHYSIOLOGY; STATISTICS AND NUMERICAL DATA; VIROLOGY;

ADENINE; ADULT; ANTIVIRAL AGENTS; DNA, VIRAL; EUROPE; FEMALE; GUANINE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HOSPITALIZATION; HUMANS; INSURANCE, HEALTH, REIMBURSEMENT; INTERFERON-ALPHA; LAMIVUDINE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MONITORING, AMBULATORY; ORGANOPHOSPHONATES; POLYETHYLENE GLYCOLS; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS;

EID: 84902659378     PISSN: 13596535     EISSN: 20402058     Source Type: Journal    
DOI: 10.3851/IMP2719     Document Type: Article

References (31)

1. Hatzakis A, Wait S, Bruix J, et al. The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference. J Viral Hepat 2011; 18 Suppl 1:1-16.
2. European Association For The Study Of The Liver. EASL Clinical Practice Guidelines: management of chronic hepatitis B virus infection. J Hepatol 2012; 57:167-185.
3. Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology 2009; 50:661-662.
4. Liaw YF, Kao JH, Piratvisuth T, et al. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update. Hepatology International 2012; 6:531-561.
5. Woo G, Tomlinson G, Nishikawa Y, et al. Tenofovir and entecavir are the most effective antiviral agents for chronic hepatitis B: a systematic review and Bayesian meta-analyses. Gastroenterology 2010; 139:1218-1229.
6. Akarca US. Chronic hepatitis B. A guideline to diagnosis, approach, management, and follow-up 2007. Turkish Association for the Study of Liver. Turk J Gastroenterol 2008; 19:207-230.
7. Cornberg M, Protzer U, Petersen J, et al. Prophylaxis, diagnosis and therapy of hepatitis B virus infection - the German guideline. Z Gastroenterol 2011; 49:871-930.
8. Sethy PK, Goenka MK. Comparison of different hepatitis B guidelines. Hep B Annual 2009; 6:55-79.
9. Cseke A, Duta NL. Anexa 9. Theraputic protocol in HBV chronic hepatitis and liver cirrhosis. Official Monitor of Romania 2010; 178 (XXII) Nr. 386 bis/ 10.06.2010:58-65.
10. European Association For The Study Of The Liver. EASL Clinical Practice Guidelines: management of chronic hepatitis B. J Hepatol 2009; 50:227-242.
11. Marcellin P, Arama V, Leblebicioglu H, et al. Chronic hepatitis B treatment initiation and modification patterns in five European countries: a 2-year longitudinal, non-interventional study. Antivir Ther 2013; 10.3851/IMP2573.
12. Boursier J, de Ledinghen V, Zarski JP, et al. A new combination of blood test and fibroscan for accurate non-invasive diagnosis of liver fibrosis stages in chronic hepatitis C. Am J Gastroenterol 2011; 106:1255-1263.
13. Castera L, Bernard PH, Le Bail B, et al. Transient elastography and biomarkers for liver fibrosis assessment and follow-up of inactive hepatitis B carriers. Aliment Pharmacol Ther 2011; 33:455-465.
14. Brown A, Goodman Z. Hepatitis B-associated fibrosis and fibrosis/cirrhosis regression with nucleoside and nucleotide analogs. Expert Rev Gastroenterol Hepatol 2012; 6:187-198.
15. Grigorescu M, Pascu O, Acalovschi M, Radu C. What is the real prevalence of the D virus infection in chronic hepatitis and liver cirrhosis in Romania? Rom J Gastroenterol 2003; 12:179-182.
16. Wedemeyer H, Manns MP. Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead. Nat Rev Gastroenterol Hepatol 2010; 7:31-40.
17. Toy M, Onder FO, Idilman R, et al. The cost-effectiveness of treating chronic hepatitis B patients in a median endemic and middle income country. Eur J Health Econ 2012; 13:663-676.
18. European Centre for Disease Prevention and Control. Hepatitis B and C in the EU neighbourhood, prevalence, burden of disease and screening policies. Stockholm: ECDC; 2010.
19. Deterding K, Constantinescu I, Nedelcu FD, et al. Prevalence of HBV genotypes in Central and Eastern Europe. J Med Virol 2008; 80:1707-1711.
20. The Viral Hepatitis Prevention Board. Epidemiology of hepatitis B in France. Viral Hepatitis 2005; 13:5.
21. Wedemeyer H, Heidrich B, Manns MP. Hepatitis D virus infection - not a vanishing disease in Europe! Hepatology 2007; 45:1331-1332, author reply 1332-1333.
22. Degertekin H, Yalcin K, Yakut M. The prevalence of hepatitis delta virus infection in acute and chronic liver diseases in Turkey: an analysis of clinical studies. Turk J Gastroenterol 2006; 17:25-34.
23. Popescu GA, Otelea D, Gavriliu LC, et al. Epidemiology of hepatitis D in patients infected with hepatitis B virus in Bucharest: a cross-sectional study. J Med Virol 2013; 85:769-774.
24. Gheorghe L, Csiki IE, Iacob S, Gheorghe C. The prevalence and risk factors of hepatitis B virus infection in an adult population in Romania: a nationwide survey. Eur J Gastroenterol Hepatol 2013; 25:56-64.
25. Rantala M, van de Laar MJ. Surveillance and epidemiology of hepatitis B and C in Europe - a review. Euro Surveill 2008; 13:18880.
26. Meffre C, Le Strat Y, Delarocque-Astagneau E, et al. Prevalence of hepatitis B and hepatitis C virus infections in France in 2004: social factors are important predictors after adjusting for known risk factors. J Med Virol 2010; 82:546-555.
27. Cornberg M, Protzer U, Dollinger MM, et al. Prophylaxis, diagnosis and therapy of hepatitis B virus (HBV) infection: the German guidelines for the management of HBV infection. Z Gastroenterol 2007; 45:1281-1328.
28. Haute Autorite de sante. Guide - affection de longe duree, hepatite chronique B. 2006. (Accessed August 2013.) Available from http://www.has-sante. fr./portail/upload/docs/application/pdf/07-007-hepatite-b-internet-sans-liste. pdf
29. Juszczyk J, Boron-Kaczmarska A, Cianciara J, et al. Polish Experts Group on HBV. Therapeutic recommendations on 2008 year (antiretroviral treatment of chronic hepatitis B). Przegl Epidemiol 2008; 62:379-381.
30. Juszczyk J, Boron-Kaczmarska A, Cianciara J, et al. Therapeutic recommendations for year 2010: antiviral treatment of chronic HBV infection. Przegl Epidemiol 2010; 64:81-82.
31. Nicolaescu GE, Ciurchea V. Romanian Ministry of Public Health. Order Nr. 1301/500 issued on 11 July 2008. Official Monitor of Romania 2008 (15 July); 176 (XX) Nr. 531:13-14.